Sr. Director, Strategic Programs & Transformation, China
AstraZeneca - Shanghai Jing'An Office
Posted Nov 11, 2026
Benefits
- Parental leave
- Not verified
- Non-birth-parent leave
- Not verified
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Not verified
- Relocation assistance
- Not verified
- Childcare support
- Not verified
- Learning budget
- Not verified
- Verification
- Not verified checked Nov 20, 2026
- Salary
- Not verified
- 401(k) match
- Reported from DOL Form 5500 industry filing (not employer-specific)
Was this benefit information wrong? Tell us.
Role
- Seniority
- Director Plus From the posting source checked Nov 16, 2026
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
Sr. Director, Strategic Programs & Transformation, China Shanghai Jing'An Office AstraZeneca is a global, science-led, patient-focused biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines for some of the world's most serious diseases. AstraZeneca has a multifaceted environment that cultivates collaboration and innovation to achieve our goals. We attract top minds, and we nurture and build talent. Within the AstraZeneca Enterprise Cell Therapy Unit, our ambition is to realize the full potential of cell therapy for people living with cancer, immune-mediated and rare diseases around the world. This unit has responsibility for the value chain from discovery through to late-stage development and commercialization. We are rapidly progressing a broad pipeline of cell therapies in collaboration with AstraZeneca's Therapeutic Area Units. China Cell Therapy is a critical component of this. It is a vital engine for innovation, discovery and development of our cell therapies and enables the clinical testing of multiple iteration of cells and in vivo therapies. This role is a critical leadership role within AstraZeneca's China Cell Therapy, responsible for the management of overall Business Improvement, Transformation, and Strategic Programs at a within the China Cell Therapy group. The ideal candidate for this role will be curious, creative, analytical with a natural leadership drive to bring solutions beyond immediate challenges; challenge the status quo and will have outstanding communication and influencing skills. This leader will share frequent interactions with senior leaders across the Enterprise Cell Therapy Unit, as well as close collaboration with leaders of
Read the full description at astrazeneca.wd3.myworkdayjobs.com. FewerJobs shows a preview and links to the original posting.
Apply link verified; last checked Nov 20, 2026.
What verified means
Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.
Related jobs
Director, Physician (Cell Therapy)
AstraZeneca - China – Beijing – BioPark
China Opportunity Translation and Project Lead, Biotherapeutics and Genetic Medicine
AbbVie Inc. - Shanghai, Shanghai, China
Investment Director, China
Medtronic - Shanghai, Shanghai, China
Sr. Manager, Biomarker Research
Merck & Co., Inc. - CHN - Shanghai - Shanghai (Tower A)